Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension
Murray Esler(Baker Heart and Diabetes Institute), Paul A. Sobotka(The Ohio State University), Michael Böhm(Saarland University), Markus P. Schlaich(The University of Western Australia), Roland E. Schmieder(Universitätsklinikum Erlangen), Henry Krum(Australian Regenerative Medicine Institute)
Cited by 464
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k